维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="M Leleu"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Bortezomib(Velcade)plus decamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:preliminary results of an IFM phase II study显示文摘	Harousseau JL Attal M Leleu X	2004	Blood2004，104，：	1
2	Pomalidomide plus low-dose Dexamethasone in relapsed or refractory multiple myeloma (RRMM) with deletion (del)17p and/or translocation t(4;14) 显示文摘	Leleu X Karlin L Macro M	2013	Blood (ASH Annual Meeting Abstracts)2013，122，：	1
3	The burden of liver disease in Europe : a review of available epidemiological data显示文摘	Blachier M Leleu H Peck-Radosavljevic M	2013	Hepatol2013，58，3：	1
4	High response rates to pomalidomide and dexamethasone in patients with refractory myeloma,final analysis of IFM 2009-02显示文摘	Leleu X Attal M Arnulf B		0，，：	1
5	Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:results of an IFM phaseⅡstudy显示文摘	Harousseau JL Attal M Leleu X	2006	Haematologica2006，91，11：	1
6	Characterization of a twocomponent high-affnity nitrate uptake system in Arabidopsis Physiology and protein-protein interaction 显示文摘	Orsel M Chopin F Leleu O	2006	Plant Physiology2006，142，：	1
7	Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study 显示文摘	Harousseau JL Attal M Leleu X	2006	Haematologica2006，91，11：	1
8	GO-SPADE:Mining sequential patterns over datasets with consecutive repetitions显示文摘	Leleu M Rigotti C Boulicaut J F	2003	Machine Learning and Data Mining2003，18，7：	1
9	Bortezomib plus dexa-methasone induction improves outcome of patients with t(4; 14)myeloma but not outcome of patients with del( 17p) 显示文摘	Avet - Loiseau H Leleu X Roussel M	2010	J Clin On-col2010，28，30：	1
10	Estimation of direct cost and resource allocation in intensive care: correlation with Omega system显示文摘	Sznajder M Leleu G Buonamico G	1998	Intensive Care Med1998，24，11：	1
11	Bortezomib plus dexamethasone induction improves outcome of patients with t (4; 14) myeloma but not outcome of patients with del(17p) 显示文摘	Avet-Loiseau H Leleu X Roussel M	2010	J Clin Oncol2010，28，30：	1
12	Bortezomib plus dexa- methasone induction improves outcome of patients with t (4;14) myeloma but not outcome of patients with del(17p) 显示文摘	Aver Loiseau H Leleu X Roussel M	2010	Clin On- col2010，28，：	1
13	Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide refractory multiple myeloma:Intergroupe Francophone du My61ome 2009-02显示文摘	LELEU X ATTAL M ARNULF B Et al	2013	Blood2013，121，11：	1
14	Bortezomib plus dexa- methasone induction improves outcome of patients with t(4;14) my- eloma but not outcome of patients with del(17p) 显示文摘	Avet-Loiseau H Leleu X Roussel M	2010	J Clin Oncol2010，28，30：	1
15	Trends in extreme daily rainfall across the south Pacific and celationship to the south Pacific convergence zone 显示文摘	Griffiths G M Salinger M J Leleu I	2003	International Journal of Climatology2003，23，8：	1
16	Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:results of an IFM phase Ⅱ study显示文摘	Harousseau JL Attal M Leleu X	2006	Haematologica2006，91，11：	1
17	Pomalidomide pluslow-dose dexamethasone is active and well tolerated inbortezomib and lenalidomide-refractory multiple myeloma:Intergroupe Francophone du Myelome 2009-02显示文摘	LELEU X ATTAL M ARNULF B	2013	Blood2013，121，11：	1
18	Bortezomib plus dexametha- sone as induction treatment prior to autologous stem cell transplan- tation (ASCT) in patients with newly diagnosed multiple myeloma: Preliminary results of an IFM phase I1 study 显示文摘	Harousseau JL Attal M Leleu X	2006	Hematological2006，91，11：	1
19	Resveratrolexerts antiproliferative activity and induces apoptosis inWaldenstrom's macroglobulinemia 显示文摘	ROC CARO A M LELEU X SACCO A	2008	Clin Cancer Res2008，14，6：	1
20	Bortezomib plusdexamethasone as induction treatment prior to autologousstem cell transplantation in patients with newly diagnosedmultiple myeloma: results of an IFM phase II study 显示文摘	Harousseau JL Attal M Leleu X	2006	Haematologica2006，91，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示